Blalock Williams’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$435K Sell
827
-88
-10% -$49.4K 0.28% 85
2026
Q1
$514K Sell
915
-11
-1% -$7.05K 0.4% 62
2025
Q4
$626K Buy
926
+2
+0.2% +$1.36K 0.5% 48
2025
Q3
$590K Sell
924
-143
-13% -$86.8K 0.52% 51
2025
Q2
$572K Buy
1,067
+38
+4% +$18.2K 0.57% 45
2025
Q1
$432K Buy
1,029
+79
+8% +$34.3K 0.48% 59
2024
Q4
$393K Buy
+950
New +$417K 0.46% 58

Other funds holding IDXX

Blalock Williams's IDXX Position: Q2 2026 in Review

Blalock Williams reduced its Idexx Laboratories (IDXX) stake by 9.6% in Q2 2026, selling an estimated $49.4K and leaving 827 shares worth $435K. The position accounts for 0.28% of the portfolio, ranked #85.

Blalock Williams first reported a position in IDXX in Q4 2024 and has held it in 7 quarters since. The position peaked at $626K in Q4 2025. 1,306 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Blalock Williams held 827 shares of Idexx Laboratories worth $435K as of Q2 2026.
  • Blalock Williams sold 88 Idexx Laboratories shares in Q2 2026, an estimated $49.4K.
  • Idexx Laboratories made up 0.28% of Blalock Williams's portfolio in Q2 2026, its #85 holding.
  • Blalock Williams first reported a position in Idexx Laboratories in Q4 2024 and has held it in 7 quarters since.
  • Blalock Williams's Idexx Laboratories position peaked at $626K in Q4 2025.
  • 1,306 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Blalock Williams's 13F filing for Q2 2026, filed 7 Aug 2026.